Sort
85,873 grants matching “alzheimers”
Aminergic Function in Aging and Alzheimers Disease
$982,923University Of South Florida · P01 · FY2002 · AG
CLINICAL EPIDEMIOLOGY OF DEMENTIA IN GENERAL PRACTICE
$982,402University Of Pittsburgh At Pittsburgh · R01 · FY2003 · AG
Somatostatin (SST)-GABAergic Interneuron Therapy for Alzheimer's Disease with ApoE4
$982,084Robert W. Mahley · Gabaeron, Inc. · R44 · FY2019 · AG
A novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease
$982,081John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc. · UH3 · FY2025 · NS
Low-Cost Platform for Ultrasensitive Fluorescent Immunoblot
$982,045Scott L Crick · Auragent Bioscience, Llc · R44 · FY2025 · GM
Monitoring real-world driver behavior for classification and early prediction of Alzheimerâs disease
$981,996Matthew Rizzo · University Of Nebraska Medical Center · R01 · FY2023 · AG
Lasting Impacts: Dynamic, Fully Natural Bioprinted 3D Human Neurovascular Biomimetic Model to Study Traumatic Brain Injury Pathophysiology
$981,821Monica Lizet Moya · Lawrence Livermore National Security, Llc · R61 · FY2021 · HL
Digital multidomain lifestyle intervention to address cognitive health and modifiable risk factors for Alzheimer's disease
$981,630Jordan Glenn · Neurotrack Technologies, Inc. · R44 · FY2022 · AG
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-1 in Neural and Cognitive Functions
$981,601Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Neuroprotective role of GLP-1 receptor agonists
$981,407Nigel H. Greig · National Institute On Aging · ZIA · FY2017 · AG
Genetic Risk Factors for Alzheimers Disease
$981,309Johns Hopkins University · R01 · FY2003 · AG
PREVENTABLE Protocol Refinement and Study Start-up Phase
$981,241Karen P Alexander · Duke University · U19 · FY2019 · AG
Dynamic Signal Processing Analyses of Neural Plasticity
$981,072Massachusetts General Hospital · R01 · FY2003 · DA
Mindfulness-based Cognitive Coping Mobile App Intervention for caregivers of individuals with Alzheimer's Disease
$980,975Bruno Kajiyama · Photozig, Inc. · R44 · FY2021 · AG
UAMS Alzheimer's Disease Core Center
$980,945University Of Arkansas Med Scis Ltl Rock · P30 · FY2003 · AG
The Proactive Screening and diagnosis of mild cognitive impairment and depression in patients aged 65 and over: An Implementation Study
$980,904Shenly Glenn · Miro Health Inc · R44 · FY2023 · AG
Investigating the role of TDP-43 mislocalization, structure, and post-translational modifications in the neuropathologically heterogeneous TDP-43 proteinopathies
$980,431Kathy L Newell · Indiana University Indianapolis · R01 · FY2025 · NS
Dementia with Lewy Bodies Consortium
$980,318James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · U01 · FY2016 · NS
Core B: University of Kentucky Alzheimer's Disease Core Center
$979,876Gregory A Jicha · University Of Kentucky · P30 · FY2021 · AG
Regulation of Neuronal Excitability (P01)
$979,777Daniel Johnston · University Of Texas At Austin · P01 · FY2006 · NS
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
$979,652Bruce A Yankner · Harvard Medical School · R01 · FY2018 · AG
Drugs On Learned & Spontaneous Behavior Of Experimental Animals
$979,645Steven Goldberg · National Institute On Drug Abuse · ZIA · FY2011 · DA
Development of a therapeutic nanobody targeting brain TNFa for the treatment of Alzheimer Disease
$979,592Marco Taglietti · Nanonewron Llc · R42 · FY2025 · AG
Technology-Enabled Financial Planning for Caregivers and Clients with Reduced Capacity
$979,528John E Porterfield · Bridgesource Medical Corporation · R44 · FY2022 · AG
Reimagining Precision Medicine Approaches to AD Diagnosis
$979,381Gil Dan Rabinovici · University Of California, San Francisco · R35 · FY2021 · AG